Research article · 31 Jan 2016
Conference abstractPublished 17 Aug 2015
iCRT-deter; a new approach to abuse deterrent technologies using inorganic matrices for controlled release
Lucideon, UK
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Opioid medications are prone to abuse (either intentionally or accidentally) by patients, and cost the US healthcare system tens of billions of USD$ per year. FDA is putting increasing pressure on manufacturers to reduce the risk of misuse of these drugs by developing “abuse-deterrent formulations”. This, ironically, is slowing the introduction of new, improved medications to patients in need, even though the intention is to improve the patients’ safety. Opioids are the most prominent class of addictive drugs, but other classes of drugs that may benefit from such technologies will also be discussed, for example amphetamines and benzodiazepines. Many of the currently available technologies either provide mechanical or chemical barriers to abuse, and some of the marketed technologies will be highlighted and critiqued. Inorganic controlled release carriers are receiving growing attention from pharmaceutical companies due to the ability to tightly control and manipulate the carrier microstructure and thus drug release rates. Lucideon has developed a proprietary platform (iCRT-deter) that exploits two inorganic materials and is ultimately also a new approach to providing abuse deterrent properties to oral formulations. The technology concept, a non-confidential scientific explanation of the effects and mechanism, and supporting pre-clinical data will be discussed. This event will be the first time much of this information and data has been released into the public domain and the first time Lucideon has ever presented on the technology at a conference.
Subjects
ChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Fabrication of novel acrylic-based hdrogel for controlled release of organic and inorganic fertilizers
Conference abstract · 18 Sep 2020
Challenges and Opportunities in the Development of Abuse Deterrent Transdermal Opioid Therapies
Short communication · 3 Aug 2020
Biomaterials 2019: New approaches to simulation of enzymatic reactions: Mimetic catalysis - Tofik M Nagiev - Nagiev Institute of Catalysis and Inorganic Chemistry
Research article · 2014
Relative Bioavailability Study of an Abuse-Deterrent Formulation of Extended-Release Oxycodone with Sequestered Naltrexone (ALO-02) Versus Immediate-Release Oxycodone Tablets in Healthy Volunteers
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectChemistry
- BylineArticles whose byline prints “Mark Cresswell”
